arrow
M

Mark J. Smyth

QIMR Berghofer Medical Research Institute
H指数:172
被引数:11.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell (vol 18, pg 1004, 2017)

通过将效应NK细胞转化为1型先天淋巴样细胞来逃避肿瘤免疫 (第18卷,1004页,2017页)

2024-03-210
OA
The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation (vol 21, pg 1205, 2020)
2024-02-150
OA
CIS is a potent checkpoint in NK cell-mediated tumor immunity (vol 17, pg 816, 2016)
2023-12-120
OA
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy
IMMUNITY
IF26.3
2020-10-01109
OAAI
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells
IMMUNITY
IF26.3
2020-10-0193
OAAI
The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation
2020-08-24114
OAAI